Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPM1B | O75688 | 1/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.36 |
| ▸ | LGALS8 | O00214 | 2/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.31 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.31 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.31 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.31 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.31 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.31 |
| ▸ | M6PR | P20645 | 2/20 | 0.30 |
| ▸ | MGAM | O43451 | 2/20 | 0.30 |
| ▸ | SI | P14410 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11956832 | 1.00 | PPM1B (0.36) | PPM1BPTPN1PPP1CCLGALS8CYP2C19 | |
| SCHEMBL17548801 | 1.00 | PPM1B (0.36) | PPM1BPTPN1PPP1CCLGALS8CYP2C19 | |
| SCHEMBL10291379 | 1.00 | PPM1B (0.36) | PPM1BPTPN1PPP1CCLGALS8CYP2C19 | |
| SCHEMBL13640598 | 1.00 | PPM1B (0.36) | PPM1BPTPN1PPP1CCLGALS8CYP2C19 | |
| SCHEMBL24212703 | 0.85 | LGALS8 (0.36) | PPM1BPTPN1PPP1CCLGALS8MEN1 | |
| SCHEMBL17267039 | 0.85 | LGALS8 (0.36) | PPM1BPTPN1PPP1CCLGALS8MEN1 | |
| SCHEMBL22828540 | 0.85 | LGALS8 (0.36) | PPM1BPTPN1PPP1CCLGALS8MEN1 | |
| SCHEMBL10258933 | 0.83 | PPM1B (0.33) | PPM1BPTPN1PPP1CCCYP2C19 | |
| SCHEMBL18869635 | 0.80 | PPM1B (0.37) | PPM1BPTPN1PPP1CCCYP2C19MEN1 | |
| SCHEMBL15883969 | 0.77 | F10 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120157407-A1 | GALACTOSE-PRONGED POLYSACCHARIDES IN A FORMULATION FOR ANTIFIBROTIC THERAPIES | PRO-PHARMACEUTICALS, INC. | 2012-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120157407-A1 | GALACTOSE-PRONGED POLYSACCHARIDES IN A FORMULATION FOR ANTIFIBROTIC THERAPIES | TPSG1, MMP1, COLGALT1 | PPM1B 1600/4885PTPN1 1201/4885PPP1CC 1393/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.